Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 204

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation

Open access
Yan, Helen H N, Lai, Jeffrey C W, Ho, Siu Lun, Leung, Wai Keung, Law, Wai Lun, Lee, Janet F Y, Chan, Anthony K W, Tsui, Wai Yin, Chan, Annie S Y, Lee, Bernard C H, Yue, Sarah S K, Man, Alice H Y, Clevers, Hans, Yuen, Siu Tsan, Leung, Suet Yi·2017·Gut

Abstract

Objective: Serrated polyps (hyperplastic polyps, sessile or traditional serrated adenomas), which can arise in a sporadic or polyposis setting, predispose to colorectal cancer (CRC), especially those with microsatellite instability (MSI) due to MLH1 promoter methylation (MLH1 me+ ). We investigate genetic alterations in the serrated polyposis pathway. Design: We used a combination of exome sequencing and target gene Sanger sequencing to study serrated polyposis families, sporadic serrated polyps and CRCs, with validation by analysis of The Cancer Genome Atlas (TCGA) cohort, followed by organoid-based functional studies. Results: In one out of four serrated polyposis families, we identified a germline RNF43 mutation that displayed autosomal dominant cosegregation with the serrated polyposis phenotype, along with second-hit inactivation through loss of heterozygosity or somatic mutations in all serrated polyps (16), adenomas (5) and cancer (1) examined, as well as coincidental BRAF mutation in 62.5% of the serrated polyps. Concurrently, somatic RNF43 mutations were identified in 34% of sporadic sessile/traditional serrated adenomas, but 0% of hyperplastic polyps (p=0.013). Lastly, in MSI CRCs, we found significantly more frequent RNF43 mutations in the MLH1 me+ (85%) versus MLH1 me− (33.3%) group (p<0.001). These findings were validated in the TCGA MSI CRCs (p=0.005), which further delineated a significant differential involvement of three Wnt pathway genes between these two groups (RNF43 in MLH1 me+ ; APC and CTNNB1 in MLH1 me− ); and identified significant co-occurrence of BRAF and RNF43 mutations in the MSI (p<0.001), microsatellite stable (MSS) (p=0.002) and MLH1 me+ MSI CRCs (p=0.042). Functionally, organoid culture of serrated adenoma or mouse colon with CRISPR-induced RNF43 mutations had reduced dependency on R-spondin1. Conclusions: These results illustrate the importance of RNF43, along with BRAF mutation in the serrated neoplasia pathway (both the sporadic and familial forms), inform genetic diagnosis protocol and raise therapeutic opportunities through Wnt inhibition in different stages of evolution of serrated polyps.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2016-311849

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 204

Metadata

Authors
Yan, H. H. N., Lai, J. C. W., Ho, S. L., Leung, W. K., Law, W. L., Lee, J. F. Y., Chan, A. K. W., Tsui, W. Y., Chan, A. S. Y., Lee, B. C. H., Yue, S. S. K., Man, A. H. Y., Clevers, H., Yuen, S. T., & Leung, S. Y.
Venue
Gut
Publisher
BMJ
Published
2016-06-21
Volume
66
Issue
9
Pages
1645-1656
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2472184398
Cited by
204
References
16
FWCI
16.16
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation. https://app.cochat.ai/papers/10.1136/gutjnl-2016-311849
The paper
Yan, H. H. N., Lai, J. C. W., Ho, S. L., Leung, W. K., Law, W. L., Lee, J. F. Y., Chan, A. K. W., Tsui, W. Y., Chan, A. S. Y., Lee, B. C. H., Yue, S. S. K., Man, A. H. Y., Clevers, H., Yuen, S. T., & Leung, S. Y. (2017). RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation. Gut. https://doi.org/10.1136/gutjnl-2016-311849

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.